HNI vs Masco
HNI and MAS side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How HNI and MAS compare
Masco is the larger company, worth 4.8 times as much as HNI ($16.0B against $3.4B).
On earnings, Masco is cheaper: it trades at 18.0× trailing earnings, against 425× for HNI.
HNI grew revenue faster over the last twelve months (70.1% versus 0.95% for Masco).
Masco keeps more of each dollar of sales as profit, with a net margin of 12.1% compared with 0.10% at HNI.
Both pay dividends: HNI yields 2.2% and Masco 1.2%.
Masco scores higher on the StockData Score (15 against 7 for HNI), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | HNI | MAS |
|---|---|---|
| Size and price | ||
| Market cap | $3.4B | $16.0B |
| Share price | $46.75 | $83.22 |
| Change, 1 year | 19.3% | 37.0% |
| Change, 5 years | 14.7% | 24.1% |
| Beta (5Y) | 0.91 | 0.74 |
| Employees | 20K | 18K |
| StockData Score | ||
| Total score | 7 | 15 (better) |
| Valuation score | 0 | 1 (better) |
| Growth score | 1 | 3 (better) |
| Performance score | 3 | 3 |
| Health score | 1 | 4 (better) |
| Dividend score | 2 | 4 (better) |
| Valuation | ||
| P/E | 425× | 18.0× (better) |
| P/S | 0.8× (better) | 2.1× |
| P/B | 1.9× | – |
| EV/EBITDA | 16.2× | 12.4× (better) |
| P/FCF | – | 15.4× |
| PEG | – | 8.71 |
| FCF yield | – | 6.5% |
| Fair value | $24.52 | $81.43 |
| Margin of safety | −90.7% | −2.2% (better) |
| Growth | ||
| Revenue growth (TTM) | 70.1% (better) | 0.95% |
| Revenue growth, 5Y average | 7.7% (better) | 1.0% |
| Net income growth (TTM) | −97.1% | 12.0% (better) |
| EPS growth (TTM) | −96.4% | 18.8% (better) |
| EPS growth, 5Y average | 2.5% (better) | −3.4% |
| Profitability | ||
| Gross margin | 41.0% (better) | 37.6% |
| Operating margin | 2.0% | 17.9% (better) |
| Net margin | 0.10% | 12.1% (better) |
| FCF margin | – | 13.6% |
| Return on equity | 0.33% | – |
| Return on invested capital | 2.1% | 46.6% (better) |
| Financial health | ||
| Debt / equity | 0.76 | – |
| Net debt / EBITDA | 4.41 | 1.73 (better) |
| Interest coverage | – | 12.8× |
| Current ratio | 1.36 | 1.83 (better) |
| Altman Z-score | 1.74 | 4.09 (better) |
| Piotroski F-score | 6 | 8 (better) |
| Dividends and buybacks | ||
| Dividend yield | 2.2% (better) | 1.2% |
| Payout ratio | 1937% | 27.5% |
| Years of dividend growth | 15 (better) | 12 |
| Dividend growth, 5Y average | 2.0% | 17.9% (better) |
| Buyback yield | 0.01% | 6.7% (better) |
| Shareholder yield | 2.2% | 7.8% (better) |
| Ownership | ||
| Held by institutions | 87.8% | 104% |
| Held by insiders | 1.9% | 0.34% |
| Insider net buying, 12 months | −$4.8M (better) | −$7.9M |
| Superinvestors holding | – | 2 |
| Short interest, % of float | 5.4% | 4.1% |
Go deeper
- HNI stock overview
- HNI income statement
- HNI valuation and score
- MAS stock overview
- MAS income statement
- MAS valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.